SCHEMBL19631376

SCHEMBL19631376

CN1CCOCC1CF

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25807046 1.00
SCHEMBL15038194 1.00
SCHEMBL30484 0.80
SCHEMBL19267113 0.80
SCHEMBL13090159 0.80
SCHEMBL7920458 0.78
SCHEMBL9024948 0.78
SCHEMBL21369194 0.78
SCHEMBL19172864 0.78
SCHEMBL12439525 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220153752-A1 DIFLUOROMETHYL-AMINOPYRIDINES AND DIFLUOROMETHYL-AMINOPYRIMIDINES TORQUR AG (CH) 2022-05-19 US disclosed
US-11186591-B2 Difluoromethyl-aminopyridines and difluoromethyl-aminopyrimidines UNIVERSITÄT BASEL (CH) 2021-11-30 US disclosed
US-10993947-B2 Treatment of skin lesions TORQUR (CH) 2021-05-04 US disclosed
US-20200277304-A1 DIFLUOROMETHYL-AMINOPYRIDINES AND DIFLUOROMETHYL-AMINOPYRIMIDINES TORQUR AG (CH) 2020-09-03 US disclosed
US-10640516-B2 Difluoromethyl-aminopyridines and difluoromethyl-aminopyrimidines PIQUR THERAPEUTICS AG (CH) 2020-05-05 US disclosed
US-20190290653-A1 TREATMENT OF SKIN LESIONS TORQUR AG (CH) 2019-09-26 US disclosed
US-20190284178-A1 TREATMENT OF NEUROLOGICAL DISORDERS TORQUR AG (CH) 2019-09-19 US disclosed
US-20190031682-A1 DIFLUOROMETHYL-AMINOPYRIDINES AND DIFLUOROMETHYL-AMINOPYRIMIDINES TORQUR AG (CH) 2019-01-31 US disclosed
WO-2017198347-A1 TREATMENT OF SKIN LESIONS PIQUR THERAPEUTICS AG (CH) 2017-11-23 WO disclosed